Net revenue for Q4 2025 reached $3,551 million, marking a 29.3% increase compared to Q4 2024. Full year 2025 net revenue was $12,911 million, up 28.2% from full year 2024. Net income for Q4 2025 was $49.6 million, a significant improvement from $4.3 million in Q4 2024. Full year 2025 saw a net income of $104.8 million, a turnaround from a net loss of $68.9 million in full year 2024. Adjusted EBITDA for Q4 2025 grew by 40.7% to $184 million, and for the full year 2025, it increased by 34.2% to $618 million. Operating cash flow for full year 2025 dramatically increased to $490 million, compared to $24 million in full year 2024. The company's leverage ratio improved to 2.99x as of December 31, 2025, down from 4.16x on December 31, 2024. BrightSpring acquired 107 home health and hospice branches as part of the Amedisys and LHC acquisition. The company repurchased 1,500,000 shares of common stock for approximately $43.2 million in connection with an October 2025 secondary offering. The planned divestiture of the Community Living business to Sevita, announced on January 20, 2025, is expected to close by the end of the first quarter of 2026. For full year 2026, BrightSpring projects revenues between $14,450 million and $15,000 million (11.9% to 16.2% growth) and Adjusted EBITDA between $760 million and $790 million (23.1% to 27.9% growth).